Dramatic Response to Convalescent Hyperimmune Plasma in Association With an Extended Course of Remdesivir in 4 B Cell-Depleted Non-Hodgkin Lymphoma Patients With SARS-Cov-2 Pneumonia After Rituximab Therapy.

Furlan, Anna; Forner, Gabriella; Cipriani, Ludovica; Vian, Elisa; Rigoli, Roberto; Gherlinzoni, Filippo; Scotton, Piergiorgio

Furlan, Anna; Forner, Gabriella; Cipriani, Ludovica; Vian, Elisa; Rigoli, Roberto; Gherlinzoni, Filippo; Scotton, Piergiorgio.

Furlan A; Hematology Unit, Azienda ULSS2 Marca Trevigiana, Italy. Electronic address: anna.furlan@aulss2.veneto.it.
Forner G; Infectious Disease Unit, Azienda ULSS2 Marca Trevigiana, Italy.
Cipriani L; Infectious Disease Unit, Azienda ULSS2 Marca Trevigiana, Italy.
Vian E; Microbiology Unit, Azienda ULSS2 Marca Trevigiana, Italy.
Rigoli R; Microbiology Unit, Azienda ULSS2 Marca Trevigiana, Italy.
Gherlinzoni F; Hematology Unit, Azienda ULSS2 Marca Trevigiana, Italy.
Scotton P; Infectious Disease Unit, Azienda ULSS2 Marca Trevigiana, Italy.

Clin Lymphoma Myeloma Leuk ; 21(9): e731-e735, 2021 09.

Article in English | MEDLINE | ID: covidwho-1240251

Subject(s)

Adenosine Monophosphate/analogs & derivatives; Alanine/analogs & derivatives; COVID-19/therapy; Lymphoma, Non-Hodgkin/therapy; Rituximab/therapeutic use; Adenosine Monophosphate/administration & dosage; Alanine/administration & dosage; B-Lymphocytes/pathology; COVID-19/complications; Combined Modality Therapy; Drug Administration Schedule; Humans; Immunization, Passive/methods; Immunocompromised Host; Immunosuppressive Agents/adverse effects; Immunosuppressive Agents/therapeutic use; Italy; Lymphoma, Non-Hodgkin/complications; Lymphoma, Non-Hodgkin/pathology; Lymphopenia/etiology; Lymphopenia/pathology; Lymphopenia/therapy; Male; Middle Aged; Pneumonia, Viral/complications; Pneumonia, Viral/therapy; Rituximab/adverse effects; SARS-CoV-2/physiology; Treatment Outcome; COVID-19 Drug Treatment; COVID-19 Serotherapy

Keywords

B cell depletion convalescent hyperimmune plasma remdesivir; Rituximab; SARS-CoV-2; non-Hodgkin lymphoma

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Adenosine Monophosphate / Alanine / Rituximab / COVID-19 Type of study: Case report / Prognostic study Topics: Long Covid Limits: Humans / Male / Middle aged Country/Region as subject: Europa Language: English Journal: Clin Lymphoma Myeloma Leuk Journal subject: Neoplasms Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google